Nestlé Expands CHUCKIE Ready-To-Drink Plant In Tanauan City To Bring More Happy Childhood Memories

Nestlé Philippines has expanded its CHUCKIE ready-to-drink facility in Tanauan City, adding capacity to produce another 144 million packs of chocolate milk annually.

Shaping Digital Lending In PH Through Dignity, Data, And Consumer-Centric Co-Regulation

Tala frames digital lending around dignity, data, and consumer control as the Philippines builds a more inclusive credit ecosystem.

Why Upgrading Your Fuel Is The Smarter Choice

Caltex fuels with Techron technology are designed to help clean harmful engine deposits and support more efficient vehicle performance over time.

NephroPlus Philippines Brings Kidney Health Awareness And Prevention To Indigenous Community In Oriental Mindoro

NephroPlus Philippines continues to complement dialysis care with community-based efforts that encourage prevention, early detection, and greater awareness of kidney health.

Birth Control Pills For Men Are Expected To Undergo Human Trials This 2022

Scientists are reported to be working on developing a non-hormonal birth control pill for men.

Birth Control Pills For Men Are Expected To Undergo Human Trials This 2022

96
96

How do you feel about this story?

Express Your Reaction
Like
Love
Haha
Wow
Sad
Angry

When it comes to birth control, a woman’s uterus is always the first thing that comes to mind, leaving men having difficulties having this option. On Wednesday, March 23, a team of scientists is reported to be working on developing a non-hormonal birth control pill for men. Results have shown that the drug has prevented pregnancy for mice without side effects.

Unlike women, men only have two options for birth control: male condoms and vasectomy. However, both options are not as effective and long-lasting similar to women’s birth control options. “Therefore, men need an effective, long-lasting but reversible contraceptive, similar to the birth control pill for women.” the scientists said in a press release from the American Chemical Society (ACS).

According to the research presented at the annual ACS meeting, the team of scientists from the University of Minnesota created a male birth control pill that blocks proteins from binding to Vitamin A, which plays a vital role in cell growth and reproduction. The drug showed 99 percent effectiveness in preventing pregnancy in mice, bearing no side effects.

The team gave the pill to the mice to take for four weeks and eventually caused sterility for male mice. After stopping the take of the drug, the male mice’s virility went back to normal levels after four to six weeks.

“Scientists have been trying for decades to develop an effective male oral contraceptive, but there are still no approved pills on the market,” said Md Abdullah Al Noman, a graduate student in the lab of Gunda Georg, Ph.D., at the University of Minnesota.

However, the press release also stated that most compounds undergoing clinical trials target the male sex hormone testosterone, leading to side effects such as weight gain, depression, and increased cholesterol levels. “We wanted to develop a non-hormonal male contraceptive to avoid these side effects,” Noman added.

According to Gunda Georg, a scientist at the University of Minnesota, human trials are expected to begin in the third or fourth quarter of 2022. Georg said that it is difficult to predict if a compound that looks good in animal studies will pan out in human trials, so the team is still exploring other compounds. The scientists also said they modified the existing compound and tested new structural scaffolds.

The scientists also hope that their efforts will finally develop an effective and long-lasting oral male contraceptive.

Source: https://www.acs.org/content/acs/en/pressroom/newsreleases/2022/march/non-hormonal-pill-could-soon-expand-mens-birth-control-options.html